PSI Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-30
| Closed | -$2.21K | – | 149 |
|
|
2025
Q1 | $2.21K | Sell |
30
-107
| -78% | -$7.87K | ﹤0.01% | 590 |
|
|
2024
Q4 | $8.97K | Hold |
137
| – | – | ﹤0.01% | 546 |
|
|
2024
Q3 | $10.7K | Hold |
137
| – | – | ﹤0.01% | 525 |
|
|
2024
Q2 | $10.6K | Buy |
137
+35
| +34% | +$2.72K | ﹤0.01% | 503 |
|
|
2024
Q1 | $6.93K | Buy |
102
+1
| +1% | +$68 | ﹤0.01% | 540 |
|
|
2023
Q4 | $6.79K | Hold |
101
| – | – | ﹤0.01% | 566 |
|
|
2023
Q3 | $6.83K | Buy |
101
+1
| +1% | +$68 | ﹤0.01% | 546 |
|
|
2023
Q2 | $7.17K | Hold |
100
| – | – | ﹤0.01% | 536 |
|
|
2023
Q1 | $6.95K | Buy |
100
+1
| +1% | +$70 | ﹤0.01% | 493 |
|
|
2022
Q4 | $6.7K | Sell |
99
-350
| -78% | -$23.7K | ﹤0.01% | 480 |
|
|
2022
Q3 | $25K | Buy |
449
+1
| +0.2% | +$56 | 0.01% | 298 |
|
|
2022
Q2 | $30K | Hold |
448
| – | – | 0.01% | 300 |
|
|
2022
Q1 | $30K | Buy |
448
+1
| +0.2% | +$67 | 0.01% | 313 |
|
|
2021
Q4 | $26K | Sell |
447
-400
| -47% | -$23.3K | 0.01% | 357 |
|
|
2021
Q3 | $51K | Buy |
+847
| New | +$51K | 0.02% | 288 |
|
|
2020
Q1 | – | Sell |
-1,874
| Closed | -$93K | – | 148 |
|
|
2019
Q4 | $93K | Buy |
+1,874
| New | +$93K | 0.06% | 195 |
|